Boost for research funding

A research funding package for neurodegenerative diseases will see the government pump an additional £375 million into studies covering Alzheimer’s disease, frontotemporal dementia and dementia with Lewy bodies, among other things.  While welcoming additional investment in research, Alzheimer’s Research UK (ARUK) said that “the devil is in the detail,” including whether it would be new funding and how it would be focused.  ARUK CEO Hilary Evans said: “In the latest spending review, the government missed an opportunity to deliver on its own manifesto pledge to double funding for dementia research. More than 50,000 of our campaigners were loud and clear about how much this increased funding matters to people with dementia. We now need the government to be clear about when they will honour their £160m a year ‘Dementia Moonshot’ pledge and how they will do it.”